Email this article THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
- Authors: Kamchatnov P.R.1, Kabanov A.A.1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- Issue: Vol 7, No 2 (2013)
- Pages: 73-80
- Section: PHARMACOTHERAPY
- Published: 14.07.2014
- URL: https://klinitsist.abvpress.ru/Klin/article/view/32
- DOI: https://doi.org/10.17650/1818-8338-2013-2-73-80
- ID: 32
Cite item
Full Text
Abstract
Ischemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formulation
can reduce the risk of gastric mucosal lesion, has a special efficacy. The possibilities of using other antiaggregants and indirect anticoagulants
are considered.
About the authors
P. R. Kamchatnov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Author for correspondence.
Email: pavkam7@gmail.com
Russian Federation
A. A. Kabanov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaRussian Federation
References
Supplementary files
